Alex Therapeutics, a digital health provider, and Navamedic, a Sweden-based pharmaceutical company, have partnered to develop a companion app for managing Parkinson's disease treatment.
The app will provide medication management assistance to patients using Flexilev, a prescription treatment for Parkinson's disease. It will complement the OraFID dose dispenser, offering a unique combination to help patients adhere to precise and individualized treatment regimens. Further, it is set to launch in Sweden, Norway, and Denmark in the coming year, with plans for further global expansion.
Analyst QuickTake: In January 2022 , the company partnered with Pfizer to develop a digital therapeutics (DTx) app to treat nicotine addiction. The company had also partnered with Vicore Pharma to develop a DTx for treating anxiety and depression in patients with idiopathic pulmonary fibrosis.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.